Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Anaesthetic management of patient with neurological disease: Focus on regional anaesthesia.]
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
Activities of the European multiple sclerosis platform.
[Treatment of multiple sclerosis symptoms and exacerbations].
Correction: Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
[Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
Electrolyte imbalance triggering relapse of inflammatory neuropathy.
Modulators of the Sphingosine 1-phosphate receptor 1.
Histamine H2 receptor signaling x environment interactions determine susceptibility to experimental allergic encephalomyelitis.
Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Endurance training is feasible in severely disabled patients with progressive multiple sclerosis.
A simple test of choice stepping reaction time for assessing fall risk in people with multiple sclerosis.
Elevated moral condemnation of third-party violations in multiple sclerosis patients.
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
Vitamin D deficiency in multiple sclerosis: Should testing and treatment be based on racial background?
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis.
Advanced magnetic resonance imaging in pediatric multiple sclerosis.
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.
Spatial modeling of multiple sclerosis for disease subtype prediction.
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis.
[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis].
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.
Clinical manifestations of neuromyelitis optica in male and female patients.
Pages
« first
‹ previous
…
448
449
450
451
452
453
454
455
456
…
next ›
last »